Lenalidomide in Myelodysplastic Syndrome and Multiple Myeloma

被引：0
|
作者：
Sachin R. Shah
Thu M. Tran
机构：
[1] Texas Tech University Health Sciences Center-School of Pharmacy/VA North Texas Health Care System,
[2] Huntsman Cancer Hospital,undefined
来源：
Drugs | 2007年 / 67卷
关键词：
Multiple Myeloma; Thalidomide; Bortezomib; Lenalidomide; Decitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The use of thalidomide is limited by adverse effects of sedation, constipation, neuropathy and thromboembolism. In order to discover more potent and less toxic immunomodulators than thalidomide, its chemical structure was modified and lenalidomide was formed.
引用
收藏
页码：1869 / 1881
页数：12
相关论文
共 50 条
  • [21] Lenalidomide (Revlimid) for anemia of myelodysplastic syndrome
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1232): : 31 - 32
  • [22] Lenalidomide in the treatment of multiple myeloma
    Rao, Kamakshi V.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (17) : 1799 - 1807
  • [23] Lenalidomide maintenance for multiple myeloma
    Brower, Vicki
    [J]. LANCET ONCOLOGY, 2012, 13 (06): : E238 - E238
  • [24] Thalidomide and lenalidomide in multiple myeloma
    Mazumder, Amitabha
    Jagannath, Sundar
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (04) : 769 - 780
  • [25] Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma
    Nakamura, Nobuhiko
    Kanemura, Nobuhiro
    Shibata, Yuhei
    Matsumoto, Takuro
    Mabuchi, Ryoko
    Nakamura, Hiroshi
    Kitagawa, Junichi
    Goto, Naoe
    Hara, Takeshi
    Tsurumi, Hisashi
    Moriwaki, Hisataka
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1691 - 1693
  • [26] Patient and carer experiences of living with multiple myeloma and myelodysplastic syndrome
    Roydhouse, Jessica
    Thompson, Deborah
    Nicholson, Louise
    Harrup, Rosemary
    Campbell, Julie
    Jose, Kim
    [J]. PSYCHO-ONCOLOGY, 2024, 33 (01)
  • [27] Is lenalidomide a new standard treatment for myelodysplastic syndrome?
    Andrea Kuendgen
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 396 - 397
  • [28] Lenalidomide and venous thrombosis in multiple myeloma
    Rajkumar, SV
    Blood, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (19): : 2080 - 2080
  • [29] Is lenalidomide a new standard treatment for myelodysplastic syndrome?
    Kuendgen, Andrea
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (07): : 396 - 397
  • [30] A case of lenalidomide-dependent myelodysplastic syndrome
    Miller, Ira J.
    Hsu, Wei-Tong
    Weisberger, James
    Venugopal, Parameswaran
    [J]. BLOOD ADVANCES, 2017, 1 (16) : 1238 - 1242
12345